Skip to content

DVD Lifestyle Intervention

DVD Lifestyle Intervention (D-ELITE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03260140
Acronym
D-ELITE
Enrollment
511
Registered
2017-08-24
Start date
2018-02-15
Completion date
2021-06-30
Last updated
2023-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

weight loss, lifestyle, diet, exercise, randomized controlled trial

Brief summary

Most Veterans who receive VA healthcare have obesity (41%) or are classified as overweight (37%), putting them at higher risk for multiple serious chronic health conditions. Providing evidence-based behavioral weight management programs to Veterans with obesity is a priority for the VA National Center for Health Promotion and Disease Prevention (NCP). While the VA NCP's MOVE! program-primarily delivered with in-person group visits-helps Veterans with obesity lose weight, its reach has been limited because of various barriers to care. Some Veterans may do better with a program they can complete from home at their own pace. In this trial, study investigators are examining the effectiveness among Veterans of a previously proven self-directed lifestyle intervention (called DVD Lifestyle Intervention (D-ELITE)) that targets modest, clinically meaningful weight loss over the course of a year using recorded video lessons (DVD or online streaming), written self-study aids, and optional lifestyle coaching. The study will compare participants randomly assigned to receive D-ELITE to those continuing in usual care on weight and self-reported general physical health status, one year after enrollment. Secondary outcomes include weight and general physical health status two years after enrollment; and obesity-related biometric measures (blood pressure and HbA1c) and self-report psychological and behavioral factors such as physical activity and sleep quality, at one- and two-years following enrollment. Veterans with obesity living in the western US were identified using the VA Corporate Data Warehouse (CDW), recruited to participate via mail and telephone, and randomly assigned to receive the study intervention or usual care alone. The study uses CDW to assess weight change and biometric outcomes. To assess self-report outcomes, participants completed questionnaires, by mail or telephone, at baseline and 12 months after randomization, and are currently completing 24-month follow-up questionnaires. The D-ELITE intervention focuses on gradual lifestyle behavior change aimed at improving eating habits and increasing physical activity. It encourages participants to gradually achieve and maintain a 5-10% loss of baseline body weight and at least 150 minutes of moderate-intensity physical activity, such as brisk walking, each week. The D-ELITE intervention program consists of watching one video, completing corresponding written self-guided learning materials, and tracking food intake and physical activity each week for the first 12 weeks, then working through 10 additional written handouts and continued food and activity tracking for the next nine months. Intervention participants have access to a lifestyle coach, as desired, for the full 12-month intervention period. In addition to patient outcomes, this study will examine the cost of delivering the intervention, information relevant to decision-makers and potential future dissemination. Evidence-based programs like this, which can be delivered remotely and with likely minimal resources required from the VA healthcare system, are greatly needed, especially now as the SARS-CoV-2 pandemic has required VA to rapidly transition to providing more remotely-delivered care. Impact: The DELITE trial has potential to provide the evidence needed for deciding whether a low-cost, low-technology, self-directed program can be used to expand the treatment of obesity to a population-based level by improving access to obesity treatment regardless of Veteran place of residence.

Interventions

The investigators will provide participants with the behavioral lifestyle intervention

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

The investigators will randomly assign participants to one of two groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recent VA primary care measured BMI between 30.0-44.9 kg/m2 (at facility in pacific or mountain time zone) * Access to DVD player or internet * Able to participate fully in all study protocol/procedures including informed consent

Exclusion criteria

* Inability to speak, read, or understand English * Recent weight loss interventions including use of prescription weight-loss medications, participation in group or individual weight loss programs provided by trained personnel, bariatric surgery (or plans for during the study period) * Expected weight loss because of alternate explanations such as from illness * High variability in weight due to fluctuations in volume status (ascites - liver disease, chronic heart failure) * Safety and/or adherence concerns due to severe physical or mental health issues, or life expectancy \<24 months * Pregnant, lactating, or planning to become pregnant during the study period; * Participation in other intervention studies

Design outcomes

Primary

MeasureTime frameDescription
Body WeightWeight closest to 12 months from baseline between 9-15 months post-baselineWeights were obtained from the VA electronic health record. For the weight variable, baseline is the weight used to identify Veterans for recruitment to participate.
Short Form (SF)-12 PCS12 months post baselineThe SF-12 is a health-related quality of life measure that assesses general physical (PCS) and mental health (MCS) functioning and well-being, with the PCS score serving as co-primary outcome. The investigators scored the SF-12 using QualityMetric's scoring software. PCS scores range from 0-100 with higher scores indicating better general physical health.

Secondary

MeasureTime frameDescription
Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance Survey Change12 months post baseline4-item self-report scale indicating sleep disturbance. Raw scores are converted into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher scores represent more sleep disturbance.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Survey Change12 months post baseline8-item self-report scale indicating sleep impairment. Raw scores are converted into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher scores represent more sleep impairment.
Dietary Self-efficacy12 months post baselineThree items measuring diet self-efficacy from the Patient-centered Assessment and Counseling for Exercise plus Nutrition (PACE+) Adult Psychosocial Questionnaire. Scores range from 1-5 with higher scores representing higher diet self-efficacy.
International Physical Activity Questionnaire (IPAQ)12 months post baseline7-item short form of the IPAQ, which evaluates weekly walking, vigorous and moderate-intensity activity. The investigators report here the number of participants engaging in at least 150 minutes of activity per week.
Short Form (SF)-12 Mental Component Score (MCS)12 months post baselineThe SF-12 is a health-related quality of life measure that assesses general physical (PCS) and mental health (MCS) functioning and well-being, with the MCS score assessing mental health status. The investigators scored the SF-12 using QualityMetric's scoring software. MCS scores range from 0-100 with higher scores indicating better general menal health.
Diastolic Blood Pressure (DBP)DBP closest to 12 months from baseline between 9-15 months post-baselineDBP values were obtained from the VA electronic health record. DBP is a measure of artery pressure when the heart rests between beats.
Systolic Blood Pressure (SBP)SBP closest to 12 months from baseline between 9-15 months post-baselineSBP values were obtained from the VA electronic health record. SBP is a measure of how much pressure blood is exerting against artery walls when the heart beats.
Hemoglobin A1c (HbA1c)HbA1c closest to 12 months from baseline between 9-15 months post-baselineHbA1c values were obtained from the VA electronic health record. HbA1c is a measure of the percentage of glucose in the blood.
Starting the Conversation12 months post baseline8-item self-report measure of diet quality that assesses intake of various types of food (e.g., fruit and vegetable, sugary beverages). Scores range from 0-16 with higher scores indicating better diet quality.

Countries

United States

Participant flow

Participants by arm

ArmCount
Behavioral Lifestyle Intervention
The investigators will provide participants with the the behavioral lifestyle intervention behavioral lifestyle intervention: The investigators will provide participants with the behavioral lifestyle intervention
254
Usual Care Control
participant in this arm will continue with usual care
257
Total511

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath41
Overall StudyWithdrawal by Subject14

Baseline characteristics

CharacteristicUsual Care ControlTotalBehavioral Lifestyle Intervention
Age, Continuous58.1 years
STANDARD_DEVIATION 13.58
57.4 years
STANDARD_DEVIATION 13.88
56.8 years
STANDARD_DEVIATION 14.17
Ethnicity (NIH/OMB)
Hispanic or Latino
29 Participants66 Participants37 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
223 Participants440 Participants217 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants5 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
5 Participants7 Participants2 Participants
Race (NIH/OMB)
Asian
1 Participants7 Participants6 Participants
Race (NIH/OMB)
Black or African American
32 Participants56 Participants24 Participants
Race (NIH/OMB)
More than one race
1 Participants4 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
3 Participants3 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants25 Participants16 Participants
Race (NIH/OMB)
White
206 Participants409 Participants203 Participants
Sex: Female, Male
Female
112 Participants230 Participants118 Participants
Sex: Female, Male
Male
145 Participants281 Participants136 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
4 / 2541 / 257
other
Total, other adverse events
124 / 254105 / 257
serious
Total, serious adverse events
47 / 25442 / 257

Outcome results

Primary

Body Weight

Weights were obtained from the VA electronic health record. For the weight variable, baseline is the weight used to identify Veterans for recruitment to participate.

Time frame: Weight closest to 12 months from baseline between 9-15 months post-baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionBody Weight99.8 kilogram (kg)Standard Deviation 15.8
Usual Care ControlBody Weight101.0 kilogram (kg)Standard Deviation 15
Comparison: Linear mixed model analysis comparing the average 12-month weight between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.00197.5% CI: [-3.24, -0.61]Mixed Models Analysis
Primary

Short Form (SF)-12 PCS

The SF-12 is a health-related quality of life measure that assesses general physical (PCS) and mental health (MCS) functioning and well-being, with the PCS score serving as co-primary outcome. The investigators scored the SF-12 using QualityMetric's scoring software. PCS scores range from 0-100 with higher scores indicating better general physical health.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionShort Form (SF)-12 PCS44.3 score on a scaleStandard Deviation 10.7
Usual Care ControlShort Form (SF)-12 PCS43.2 score on a scaleStandard Deviation 9.8
Comparison: Linear mixed model analysis comparing the 12-month SF-12 PCS between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.38897.5% CI: [-1.11, 2.49]Mixed Models Analysis
Secondary

Diastolic Blood Pressure (DBP)

DBP values were obtained from the VA electronic health record. DBP is a measure of artery pressure when the heart rests between beats.

Time frame: DBP closest to 12 months from baseline between 9-15 months post-baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionDiastolic Blood Pressure (DBP)77.4 millimeters of mercury (mmHg)Standard Deviation 8
Usual Care ControlDiastolic Blood Pressure (DBP)77.2 millimeters of mercury (mmHg)Standard Deviation 7.2
Comparison: Linear mixed model analysis comparing the average 12-month DBP between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.6295% CI: [-1.77, 1.05]Mixed Models Analysis
Secondary

Dietary Self-efficacy

Three items measuring diet self-efficacy from the Patient-centered Assessment and Counseling for Exercise plus Nutrition (PACE+) Adult Psychosocial Questionnaire. Scores range from 1-5 with higher scores representing higher diet self-efficacy.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionDietary Self-efficacy3.1 score on a scaleStandard Deviation 1
Usual Care ControlDietary Self-efficacy3.0 score on a scaleStandard Deviation 1
Comparison: Linear mixed model analysis comparing the average score between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.48395% CI: [-0.11, 0.23]Mixed Models Analysis
Secondary

Hemoglobin A1c (HbA1c)

HbA1c values were obtained from the VA electronic health record. HbA1c is a measure of the percentage of glucose in the blood.

Time frame: HbA1c closest to 12 months from baseline between 9-15 months post-baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionHemoglobin A1c (HbA1c)6.3 percentage of glycosylated hemoglobinStandard Deviation 1.5
Usual Care ControlHemoglobin A1c (HbA1c)6.4 percentage of glycosylated hemoglobinStandard Deviation 1.3
Comparison: Linear mixed model analysis on log-transformed HbA1c comparing the average HbA1c between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.98595% CI: [-2.57, 2.69]Mixed Models Analysis
Secondary

International Physical Activity Questionnaire (IPAQ)

7-item short form of the IPAQ, which evaluates weekly walking, vigorous and moderate-intensity activity. The investigators report here the number of participants engaging in at least 150 minutes of activity per week.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted number of participants engaging in at least 150 minutes of activity per week. The analysis population for adjusted between-group differences includes study participants with measurements at both baseline and 12 months; see Statistical Analysis 1 for those results.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Behavioral Lifestyle InterventionInternational Physical Activity Questionnaire (IPAQ)149 Participants
Usual Care ControlInternational Physical Activity Questionnaire (IPAQ)143 Participants
Comparison: Group-specific McNemar's Chi-Square tests were applied to examine the change from baseline to follow-up in dichotomized IPAQ (\>=150 vs \<150) minutes of physical activity per week. To compare intervention vs. control at 12 months, we applied an F test. The intervention effect was an odds ratio of the ratios of discordant pairs in the intervention vs the control group.p-value: 0.30895% CI: [0.85, 3.66]F test-ratio of 2 McNemar's Chi-Squares
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance Survey Change

4-item self-report scale indicating sleep disturbance. Raw scores are converted into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher scores represent more sleep disturbance.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance Survey Change52.5 T-scoreStandard Deviation 9.2
Usual Care ControlPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance Survey Change52.0 T-scoreStandard Deviation 9.3
Comparison: Linear mixed model analysis comparing the average 12-month score between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.65795% CI: [-1.02, 1.61]Mixed Models Analysis
Secondary

Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Survey Change

8-item self-report scale indicating sleep impairment. Raw scores are converted into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Higher scores represent more sleep impairment.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Survey Change51.7 T-scoreStandard Deviation 10.7
Usual Care ControlPatient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Survey Change52.2 T-scoreStandard Deviation 10.3
Comparison: Linear mixed model analysis comparing the average 12-month score between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.28195% CI: [-2.33, 0.68]Mixed Models Analysis
Secondary

Short Form (SF)-12 Mental Component Score (MCS)

The SF-12 is a health-related quality of life measure that assesses general physical (PCS) and mental health (MCS) functioning and well-being, with the MCS score assessing mental health status. The investigators scored the SF-12 using QualityMetric's scoring software. MCS scores range from 0-100 with higher scores indicating better general menal health.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionShort Form (SF)-12 Mental Component Score (MCS)47.2 score on a scaleStandard Deviation 12.4
Usual Care ControlShort Form (SF)-12 Mental Component Score (MCS)48.1 score on a scaleStandard Deviation 11.4
Comparison: Linear mixed model analysis comparing the average 12-month MCS between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.80695% CI: [-1.99, 1.55]Mixed Models Analysis
Secondary

Starting the Conversation

8-item self-report measure of diet quality that assesses intake of various types of food (e.g., fruit and vegetable, sugary beverages). Scores range from 0-16 with higher scores indicating better diet quality.

Time frame: 12 months post baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionStarting the Conversation6.2 score on a scaleStandard Deviation 2.6
Usual Care ControlStarting the Conversation6.4 score on a scaleStandard Deviation 2.7
Comparison: Linear mixed model analysis comparing the average 12-month score between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.39695% CI: [-0.61, 0.24]Mixed Models Analysis
Secondary

Systolic Blood Pressure (SBP)

SBP values were obtained from the VA electronic health record. SBP is a measure of how much pressure blood is exerting against artery walls when the heart beats.

Time frame: SBP closest to 12 months from baseline between 9-15 months post-baseline

Population: The investigators report here the unadjusted means at 12 months. The analysis population for adjusted between-group differences includes study participants with a measurement at baseline and/or 12-month follow-up; see Statistical Analysis 1 for those results.

ArmMeasureValue (MEAN)Dispersion
Behavioral Lifestyle InterventionSystolic Blood Pressure (SBP)127.3 millimeters of mercury (mmHg)Standard Deviation 11.6
Usual Care ControlSystolic Blood Pressure (SBP)126.9 millimeters of mercury (mmHg)Standard Deviation 13.3
Comparison: Linear mixed model analysis comparing the average SBP between control and intervention groups. Our analysis controlled for randomization strata: age (less than or greater than/equal to 65), BMI (at least 30/less than 35, at least 35/less than 40, or at least 40/less than for 45), and population density (rural or urban), while random effects were used to account for within-person variability.p-value: 0.98795% CI: [-2.32, 2.28]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026